US 10213388
Abuse resistant oral dosage forms
granted A61KA61K31/485A61K9/2027
Quick answer
US patent 10213388 (Abuse resistant oral dosage forms) held by Elite Laboratories, Inc. expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Elite Laboratories, Inc.
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/485, A61K9/2027, A61K9/2095, A61K9/28